![](/img/cover-not-exists.png)
Phase II trial of weekly Docetaxel, Zoledronic acid, and Celecoxib for castration-resistant prostate cancer
Kattan, Joseph, Bachour, Marwan, Farhat, Fadi, El Rassy, Elie, Assi, Tarek, Ghosn, MarwanVolume:
34
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-016-0357-4
Date:
August, 2016
File:
PDF, 469 KB
english, 2016